Low-dose naltrexone use for the management of post-acute sequelae of COVID-19

Int Immunopharmacol
05 October 2023
https://pubmed.ncbi.nlm.nih.gov/37804660/

Will LDN therapy improve the quality of life of patients with fibromyalgia? (in Polish) (News)

05 May 2023
Medexpress.pl
https://www.medexpress.pl/blogosfera/czy-terapia-ldn-poprawi-jakosc-zycia-pacjentow-z-fibromialgia/

Face Blindness & Long COVID: Prosopagnosia Is a New Symptom of Long COVID

30seconds.com
10 April 2023
https://30seconds.com/health/tip/57734/Face-Blindness-Long-COVID-Prosopagnosia-Is-a-New-Symptom-of-Long-COVID

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis

Biomedicines
As revised 23 March 2023
https://www.mdpi.com/2227-9059/11/4/1087

An Update on the Uses of Naltrexone in Clinical Practice

Natural Medicine Journal
01 August 2022
https://www.naturalmedicinejournal.com/journal/an-update-on-the-uses-of-naltrexone-in-clinical-practice